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Abstract Neuronal cell death after severe traumatic brain
injury (TBI) is caused by a complex interplay of patholog-
ical mechanisms including excitotoxicity, oxidative stress,
mitochondrial dysfunction, extensive neuroinflammation,
and ischemia–reperfusion injury. Pancreatitis-associated
protein I (PAP I/reg2) was reported to be a survival factor for
peripheral neurons, particularly sensory and motor neurons.
In rat brains, by experimental TBI as well as by kainic acid
induced brain seizure, PAP I and PAP III were found to be
up-regulated in central neurons. In this study, we performed
immunohistochemical staining in postmortem human brain
from patients who died after severe TBI to demonstrate PAP
expression on protein level in cerebellar Purkinje cells,
pyramidal and granular neurons in cerebral cortex, and
cortical neurons in the fore- and mid-brain. In primary
cultures of rat brain cortical, hippocampal, and cerebellar
neurons, we found neuroprotective effects for PAP I on
H2O2-induced oxidative stress. Moreover, serum K
?-depri-
vation induces apoptotic cell death in 55% of cerebellar
granule neurons (CGN), whereas upon treatment with PAP I
only 32% of CGN are apoptotic. Using Western blot anal-
yses, we compared protein phosphorylation in neuronal
signaling pathways activated by PAP I versus Interleukin-6
(IL-6). We found a rapid activation of Akt-kinase phos-
phorylation by PAP I with a peak at 15 min, whereas IL-6
induces Akt-phosphorylation lasting longer than 30 min.
Phosphorylation of MAP-42/44 kinases is stimulated in a
comparable fashion. Both, IL-6 and PAP I increase phos-
phorylation of NFjB for activation of gene transcription,
whereas only IL-6 recruits STAT3 phosphorylation, indi-
cating that STAT3 is not a target of PAP I transcription
activation in brain neurons. Application of the Akt-inhibitor
Wortmanin reveals only a partial inhibition of PAP
I-dependent protection of CGN from H2O2-induced oxida-
tive stress. Based on our findings, we suggest that PAP I is
a long lasting neurotrophic signal for central neurons.
The neuroprotective effects parallel those that have been
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described for effects of PAP I in ciliary neurotrophic factor
(CNTF)-mediated survival of sensory and motor neurons.
PAP I may act in autocrine and/or paracrine fashion and thus
may contribute to endogenous protective mechanisms rel-
evant under harmful conditions like oxidative stress, brain
injury, or neurodegeneration.
Keywords Apoptosis  Traumatic brain injury 
PAP I/reg2  Oxidative stress  Human brain 
Central neurons  Neuroprotective action
Abbreviations
AD Alzheimer’s disease
CNTF Ciliary neurotrophic factor
DMEM Dulbecco’s modified Eagle’s medium
FCS Foetal calf serum
H-IL-6 Hyper-Interleukin-6
LIF Leukemia inhibitory factor
MEM Minimal essential medium
NB Neurobasal medium
NGF Nerve growth factor
PAP Pancreatitis-associated protein
Reg Regenerating gene
wtm Wortmannin
Introduction
The pathogenesis of traumatic brain injury (TBI) is char-
acterized by an interplay between excitotoxicity, oxidative
stress, mitochondrial dysfunction, edema due to breakdown
of the blood–brain barrier, an extensive neuroinflammatory
response, and apoptosis caused by ischemia–reperfusion
injury (Maas et al. 2008; Mazzeo et al. 2009).
The PAP/regenerating gene (Reg) family comprises a
group of related genes grouped into subclasses I–IV which
code for lectin-like proteins crucially involved in the
regulation and modulation of inflammatory processes
(Drickamer and Dwek 1995; Zhang et al. 2003; Graf et al.
2006). Several reports demonstrate that Reg proteins have
functional roles in the peripheral nervous system (PNS).
Pancreatitis-associated protein I (PAP I) was found to be a
survival factor for motor neurons by acting as Schwann cell
mitogen which is constitutively expressed during devel-
opment and may be transcriptionally regulated by cyto-
kines of the Interleukin-6 (IL-6) family (Livesey et al.
1997). During motor neuron development, PAP I contrib-
utes via Akt/PI3 kinase activation to the signaling path-
ways by which ciliary neurotrophic factor (CNTF) supports
neuronal survival (Nishimune et al. 2000). After sciatic
nerve transection, PAP I expression is rapidly upregulated
in sensory neurons suggesting a distinct role in the
peripheral nerve injury response (Averill et al. 2002).
Expression of PAP I and PAP II is strongly induced in
dorsal root ganglion (DRG) neurons following peripheral
tissue inflammation and nerve injury suggesting an
important role in the modulation of spinal sensory path-
ways in chronic pain states (He et al. 2010). PAP III
appears to have a specific role in peripheral nerve regen-
eration (Namikawa et al. 2005, 2006). Very recent reports
from rat models of brain injury, particularly, in neuroin-
flammation associated with TBI (Ampo et al. 2009) as well
as in kainic acid-induced brain seizure (Kawahara et al.
2011) demonstrate elevated PAP I and PAP III expression
also in central neurons.
Until now, only few reports demonstrate increased PAP
expression in human brain, particularly, in Alzheimer’s
disease (AD) brain and plaques derived from AD brain as
well as in developing human brain (de la Monte et al. 1990;
Duplan et al. 2001). The aim of this study was to investi-
gate the potential neuroprotective effects of PAP and their
underlying signal transduction pathways. Furthermore, we
aimed to demonstrate the expression of PAP in neurons in
brains of TBI patients and of rats.
Experimental Procedures
Materials
Neurobasal medium (NB), B-27 Supplement, L-glutamine,
Minimal Essential Medium (MEM), trypsin, penicillin, and
streptomycin were purchased from Invitrogen Gibco.
Defined fetal calf serum (FCS) Gold was from PAA Lab-
oratories, Pasching, Austria. Bovine serum albumin (BSA)
was obtained from Sigma. Wortmannin (wtm) was pur-
chased from Calbiochem.
Cytokines and Antibodies
The fusion protein Hyper-IL-6 (H-IL-6) was expressed in
stably transfected CHO cells and purified to homogeneity
as described (Fischer et al. 1997). Rat recombinant PAP I
was expressed in Pichia pastoris and purified as described
(Schiesser et al. 2001). Anti-human PAP and PAP anti-
bodies were generated as described (Li et al. 2009). Poly-
clonal antibodies raised against phospho-Ser473 Akt,
phospho-Thr202/Tyr204 p44/p42-MAP kinases, phospho-
Ser536 NFjB p65, and phospho-Tyr705 STAT3 were from
Cell Signaling Technology. Monoclonal anti-beta-actin
antibody was from Sigma. Polyclonal anti rat PAP I anti-
body was raised in rabbits against the recombinant protein
as described (Schiesser et al. 2001).
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Primary Neuronal Cell Cultures
All media for culture and handling of neuronal cells were
adjusted to High-potassium (HK) media by addition of KCl
to a final K?-concentration of 25 mM from the standard
5.4 mM present within the media. Primary neurons from
different brain regions were prepared from newborn Wistar
rats (postnatal day 1) as described (Brewer et al. 1993) with
minor modifications. Hippocampi, cerebella, and cortices
were dissected and meninges removed. Tissues were first
slightly triturated with a sterile Pasteur pipette followed by
trituration with a fire-polished Pasteur pipette (opening
reduced to 50–70% of its normal diameter) until no visible
aggregates of tissue remained. After 2-3 min tissue seg-
ments, larger debris settled down, and supernatants con-
taining single cells were transferred to fresh tubes. The
trituration procedure was repeated until no visible aggre-
gates of tissue remained. Single cell suspensions were
centrifuged at 2009g for 5 min, and cell pellets were
resuspended in HK-NB supplemented with 0.5 mM
L-glutamine and 1% penicillin–streptomycin sulfate. After
counting, cells were diluted with specific culture media,
seeded at a density of 6 9 105 cells/cm2 into poly-
D-lysine-coated 96-well or 24-well plates (Beckton &
Dickinson) and cultured at 37C in an atmosphere of 5%
CO2 and 100% humidity. Specific media for cerebellar and
cortical neurons were HK-MEM supplemented with glu-
cose (final 25 mM), 0.5 mM L-glutamine, 0.23 mM
Na-Pyruvate, 1% penicillin–streptomycin sulfate, and 5%
FCS. Hippocampal cells were grown in HK-NB with 1%
B-27 supplement, 0.5 mM L-glutamine, and 5% FCS. For
growth arrest of non-neuronal cells, 10 lM cytosine arab-
inofuranoside (Sigma) was added to cultures 3 days after
seeding. Every 3 days in culture, one-half of the medium
was removed and replaced by fresh serum-free HK medium
to adjust to the original volume. After 7 days in culture
(DIV7), cells consisted of almost 99% neurons and were
used for the experiments.
H2O2-Induced Oxidative Stress and K
?-Deprivation
Oxidative stress was induced by administration of
50–150 lM H2O2 for 24 h in serum-free HK-NB. After-
ward, H2O2 was washed out, and cells were incubated in
HK-NB media for further 24 h followed by determination
of neurotoxicity. Recombinant PAP I was added simulta-
neously with the toxic stimulus and added again after H2O2
removal for another 24 h. For K?-deprivation, cells were
cultured for 24 h in freshly added serum-free Low-potas-
sium medium (LK; NB with 2% B-27 supplement, 0.5 mM
L-glutamine, 5.4 mM K? final, and 1% penicillin–strepto-
mycin sulfate) containing vehicle or recombinant PAP I at
200 ng/ml.
Cell Viability Assays
Cell viability was either determined by measuring lactate
dehydrogenase (LDH) release into the cell culture media or
quantitated by counting the number of dead cells using
DAPI or TUNNEL assay. Neurotoxicity upon oxidative
stress was measured by release of LDH from the cytosol of
damaged cells into the supernatant as described by the
manufacturer (Roche Diagnostics). Concentrations of H2O2
needed to induce half-maximal toxicity was routinely
determined in independent experiments using sister cul-
tures. For measurement of apoptosis after K?-deprivation,
cells were treated for DAPI staining as described by the
manufacturer (Roche Diagnostics). Cells were stained with
1 lg/ml DAPI in Methanol for 15 min at 37C. After
washing with Methanol, cells were covered with PBS, and
the ratio of condensed versus intact nuclei was quantitated
in a fluorescence microscope. A TUNEL assay was per-
formed using Roche apoptosis detection kit according to
the manufacturer’s instructions (Roche Diagnostics). After
fixation, labeling (50 ll TUNEL reaction mixture consist-
ing of 45 ll TUNEL label plus 5 ll TUNEL enzyme) and
PBS wash, the number of apoptotic cells was counted in a
fluorescence microscope.
Immunohistochemical Staining of PAP
Sections of human brains were prepared following autopsy.
Conventional formalin fixation and paraffin embedding
followed. Antigen retrieval was performed by boiling
sections in a microwave oven, followed by blocking and
exposure to the human PAP antibodies as described pre-
viously (Graf et al. 2002).
PAP I ELISA
Rat PAP I was measured using an isoform-specific ELISA
as described (Graf et al. 2002).
Western Blot Analysis
Primary cerebellar neurons were washed with NB once
and incubated in NB for 3 h to reduce basal activation.
Afterward, neurons were stimulated with vehicle (control),
H-IL-6, or PAP I. After 0, 15, and 30 min, the medium was
removed, and cells were lyzed in 29 Laemmli buffer.
Proteins were separated by SDS-PAGE and blotted onto
PVDF membranes. Membranes were blocked for 1 h in
phosphate-buffered saline with 5% BSA and 0.1% Tween20
at RT and incubated with primary activation-specific anti-
bodies (1:1000) against PAP I, phospho-Ser473 Akt, phos-
pho-Thr202/Tyr204 p44/p42-MAP kinases, phospho-Ser536
NFjB p65, and phospho-Tyr705 STAT3 overnight at 4C
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followed by horseradish peroxidase-conjugated goat anti
rabbit antibody (1:4000, Sigma). The blots were developed
using the ECL-detection system (Amersham). After ECL
detection, the membrane was rehydrated in phosphate-
buffered saline and incubated with an anti-beta-actin anti-
body (1:5000; Sigma) as an internal loading control.
Human Brain Tissue Samples and Subjects
This study was approved by the human subjects commit-
tees of Kantonale Ethikkommission Zurich.
We collected brains at autopsy from 4 patients who died
7–42 (mean 19) days after severe TBI. Causes of death
were multiorgan failure (n = 2), elevated intracranial
pressure (n = 1), and brain death (n = 1). We obtained
four additional brains from control subjects with no clinical
evidence of TBI or other neurological disorders. Those
subjects died from ruptured aortic aneurysm (n = 1), liver
failure (n = 1), drowning (n = 1), and myocardial infarc-
tion (n = 1). First-degree relatives gave written informed
consent for autopsy and tissue research.
Results
Immunohistochemical Staining of PAP in Human Brain
Immunohistochemical staining of different brain areas
consistently revealed that only neurons express PAP at
various levels while other cell types were negative for PAP
staining (Fig. 1). Sections treated with pre-immune serum
were always negative. The cerebellar cortex showed PAP-
positive Purkinje neurons only in some cases whereas the
granular cell layer as well as the molecular layer consis-
tently lacked any immune reactivity. Pyramidal and gran-
ular neurons of the cerebral cortex displayed a similar
behavior as seen in Purkinje cells while again astrocytes
and oligodendrocytes were completely negative. Cortical
neurons were also positive in the fore- and mid-brain.
In parallel experiments, we used isolated primary cul-
tures of rat brain neurons, astrocytes, and microglial cells
to monitor PAP I expression using a specific PAP I ELISA.
As shown in Supplementary Figure S1, only neurons dis-
played PAP I expression. Among the cytokines of the IL-6
family known to regulate PAP I expression, CNTF is the
strongest inducer. However, trans-signaling of H-IL-6, in
which IL-6 is covalently linked to its soluble receptor
sIL-6R, turns out to be an extraordinary strong inducer of
PAP I expression, generating high levels of long lasting
PAP I protein even when PAP I gene transcription is
already declined (Supplementary Figure S2).
PAP I Mediates Protection of Brain Neurons against
H2O2-Induced Neurotoxicity and Apoptosis Induced
by Serum K?-Deprivation
We next examined whether PAP I would have protective
effects and may rescue brain neurons from cellular damage
due to oxidative stress and apoptosis, two key features of
TBI pathogenesis. The results shown in Fig. 2a revealed
Fig. 1 Immunohistochemical staining for PAP in human brain.
a Cerebellar cortex with granular cell layer, Purkinje neurons and
molecular layer is shown. Immunohistochemistry with control serum
(a1, b1) or PAP-specific antiserum (a2–a4, b2–b4). a2–a4: Purkinje
cells either stain completely negative (a2), weakly positive (a3), or
moderately positive (a4) for PAP. b Control (b1), b2–b4: Cortical
neurons either stain completely negative (b2), weakly positive (b3),
or moderately positive (b4). Astrocytes and oligodendrocytes are
consistently negative; scale bars: 150 lm
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that maximal neurotoxicity in CGN was obtained with
200 lM H2O2 with half-maximum at about 75 lM
H2O2. Addition of recombinant PAP I protected CGN from
H2O2-induced neurotoxicity in a dose-dependent manner
(Fig. 2b, c). In addition, hippocampal and cortical neurons
were dose-dependently protected by PAP I against oxida-
tive stress-induced neurotoxicity (Fig. 2c). The highest
PAP I concentration at 200 ng/ml revealed neuroprotection
up to 60%. Apoptosis in CGN was induced by serum
K?-deprivation, and the degree of neuronal apoptosis was
assessed using TUNEL assay and DAPI staining. As shown
in Fig. 3, about 55% of neurons in LK medium are apop-
totic whereas treatment with PAP I reduces the number of
apoptotic cells to about 32%.
PAP I Versus IL-6-Induced Activation of Signaling
Pathways in Brain Neurons
Using Western blot analyses from CGN lysates, we
examined by which signaling pathways brain neurons
might respond to PAP I as compared to the neuropoietic
cytokine IL-6. As shown in Fig. 4a, a transient phosphor-
ylation of Akt-kinase was rapidly induced by PAP I with a
peak 15 min, whereas IL-6 appears to induce Akt-phos-
phorylation lasting longer than 30 min. Phosphorylation of
MAP-42/44 kinases is stimulated in comparable fashion,
however, with different intensities (Fig. 4a). For activation
of gene transcription, both IL-6 and PAP I increase phos-
phorylation of NFjB (Fig. 4b), Only IL-6 recruits STAT3
Fig. 2 PAP I-mediated protection of Rat brain neurons from H2O2-
induced neurotoxicity. a Cultured primary CGNs were treated with 0,
25, 50, 100, 200, and 400 lM of H2O2 for 1 h. Culture medium was
changed and cells incubated for further 24 h. Thereafter, neurotox-
icity was measured as LDH release into the culture medium. Values
are expressed as means ± SEM from three independently performed
experiments. b Two series of cultured primary CGN were treated with
PAP I protein at concentrations of 0 (Control), 0.2, 2, 20, and 200 ng/
ml culture medium for 24 h. Thereafter, culture media were changed.
One series was treated with 75 lM H2O2 for 1 h; the other series left
untreated. Then, cell culture media were changed and cells incubated
for further 24 h. Neurotoxicity in all cultures was measured as LDH
release into the culture medium. Values are expressed as mean-
s ± SEM from three independently performed experiments. c Cul-
tured primary hippocampal and cortical neurons were treated as
described above, except that oxidative stress was induced using
150 lM H2O2 for 1 h. Neurotoxicity was monitored as LDH release
into the culture medium. Values of LDH release for Control were set
to 100%, and all other values were normalized accordingly. Values
are expressed as means ± SEM from three independently performed
experiments
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by protein phosphorylation (Fig. 4c), indicating that
STAT3 is not a target of PAP I in brain neurons.
The Akt/PI3 Kinase Pathway only Partially Contributes
to PAP I-Mediated Neuroprotection
In light of the transient phosphorylation of Akt-kinase by
PAP I in central neurons, we investigated the contribution
of the Akt/PI3-pathway to the neuroprotective effects of
PAP I on H2O2-induced neuronal damage or whether there
might be other mechanisms that would operate in PAP
I-induced neuroprotection as well. Using the specific Akt
activation inhibitor wtm at 20 nM (IC50 about 5 nM), our
experiments revealed that only part of the PAP I-mediated
neuroprotective effect can be attributed to the Akt signaling
pathway (Fig. 5). This indicates that PAP I-specific neu-
roprotection is not confined to a single survival pathway
but that additional signaling cascades are involved.
Discussion
In this study, we demonstrate expression of PAP in post-
mortem brain from patients who died from severe TBI.
Fig. 3 PAP I-mediated protection of Rat brain neurons from apoptosis
induced by serum K?-deprivation. For induction of neuronal apoptosis,
CGNs were cultured for 24 h in serum-free HK medium (HK), LK
medium (LK), or LK medium containing 200 ng/ml of PAP I
(LK ? PAP I) and subsequently stained using TUNNEL assay and
DAPI to assess the degree of neuronal apoptosis. About 55% of neurons
in LK medium are apoptotic whereas treatment with PAP I reduces the
number of apoptotic cells to about 35%
Fig. 4 PAP I-induced signaling
mechanisms in brain neurons.
Cultured primary CGNs were
unstimulated (Control) or
stimulated for 5, 15, and 30 min
either with PAP I (200 ng/ml)
or H-IL-6 (20 ng/ml),
respectively. Treatment with
H-IL-6 served as positive
control. Cell lysates were
subjected to SDS-PAGE and
Western blot analysis using
antibodies raised against
phospho-Ser473 Akt (a),
phospho-Thr202/Tyr204 p44/
p42-MAP kinases (a), phospho-
Ser536 NFjB p65 (b), and
phospho-Tyr705 STAT3 (c) as
compared to ß-actin. One
representative result from two
individually performed
experiments is displayed
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In accordance to studies in animal models of brain injury
(Ampo et al. 2009; Kawahara et al. 2011), only neurons are
found to express PAP. Ampo and coworkers induced TBI
by weight drop in rat brains and, using immunohisto-
chemical double-staining analyses, showed that PAP I- and
PAP-III protein expression was localized in a subpopula-
tion of neurons within the peri-injured region. PAP I
induction reached maximum levels at day 1–3 followed by
a decline to day 7 post TBI. Moreover, transient up-regu-
lation of cytokine mRNAs coding for TNF-a with a peak at
1 h, for IL-1b and IL-6 with peak levels at 4 h after TBI
were found. Whereas TNF-a mRNA levels remain elevated
up to 7 days, those for IL-1b and IL-6 are clearly termi-
nated or return to a baseline at 1 day post TBI (Ampo et al.
2009). These in vivo data and the results on PAP I
expression in H-IL-6-stimulated PC 12 cells provided in
our Figure S2 clearly demonstrate a high level, long lasting
expression of PAP I even when cytokine-induced gene
transcription is already declined.
Moreover, our data in Figure S1 show that PAP I
expression in CGN by IL-6 alone is less efficient as com-
pared to the designer cytokine H-IL-6 in which IL-6 is
covalently linked to its soluble receptor sIL-6R (Fischer
et al. 1997). This indicates a major contribution of the
process of trans-signaling to neuronal PAP I expression.
IL-6 is a member of the family of gp130 cytokines which
exert signal transduction by binding to the cellular gp130
transducing component either via a plasma-membrane-
bound receptor IL-6R or by a soluble IL-6 receptor sIL-6R.
The principle of trans-signaling via sIL-6R enlarges the
spectrum of IL-6 target cells, among them rat sympathetic
and DRG neurons (Jones et al. 2005; Rose-John et al.
2007). From previous studies in our laboratory, it is known
that rat sympathetic neurons contain only a marginal
number of membrane-bound IL-6 receptors and strongly
respond to IL-6 via trans-signaling (Ma¨rz et al. 1998,
1999). In vivo, plasma levels of sIL-6R in healthy
individuals were found to be in the range of about
25–35 ng/ml and elevated levels associated with numerous
inflammatory disease states such as Crohn’s disease,
rheumatoid arthritis (RA), juvenile RA, and osteoarthritis
(Rose-John et al. 2007). However, so far nothing is known
about the levels of sIL-6R in injured organ tissues such as
TBI brain. Thus, it would be interesting to investigate
sIL-6R levels in TBI brain as it may be speculated that in a
neuroinflammatory state as in the TBI brain, high levels of
sIL-6R may be generated to support the protective actions
of the cytokine and its secondary factors such as PAP.
Recently, we reported gene chip analyses in which we
monitored the gene sets recruited by H-IL-6 as compared to
Nerve growth factor (NGF) in PC12 cells as a valid model
for neuronal differentiation and survival (Kunz et al. 2009).
We found that H-IL-6 actions include up-regulation of
‘secondary’ signals such as growth factors and other
functionally related extracellular proteins including several
members of the Reg/PAP family, in particular, regenerat-
ing islet-derived 3 alpha (REG3A), PAP I, REG1A/Pan-
creatic stone protein (PSP), and REG3G/PAP II (Kunz
et al. 2009). These factors may synergize with IL-6 and
other cytokines and/or may take over further autocrine and
paracrine tasks to control short-and long-term effects as
part of a local microenvironment suitable to improve
neuronal growth, differentiation, and survival in an injured
brain region.
An important cellular target of IL-6 actions in the brain
is the oligodendrocyte. IL-6 as well as H-IL-6 have been
shown to enhance survival and differentiation of oligo-
dendrocyte precursor cells (Valerio et al. 2002) and to
prevent neuron as well as oligodendrocyte degeneration
following excitotoxic injury (Pizzi et al. 2004). Moreover,
H-IL-6 was found to act as a stimulator of myelination of
embryonic stem cell-derived oligodendrocytes (Zhang
et al. 2006). These observations are in line with peripheral
myelin producing Schwann cells, known to respond to PAP
Fig. 5 Effect of Akt signaling inhibition on PAP I-mediated neuro-
protection. Cultured CGNs were treated with H2O2 (75 lM), H2O2
(75 lM) plus wortmannin (wtm; 20 nM; IC50 at about 5 nM), H2O2
(75 lM) plus PAP I (200 ng/ml) or H2O2 (75 lM) plus PAP I
(200 ng/ml) plus wtm (20 nM) for 1 h. Wtm was applied 30 min
before addition of PAP I. Neurotoxicity was measured as LDH release
into the culture medium. Values are expressed as means ± SEM from
three independently performed experiments
Cell Mol Neurobiol (2011) 31:1141–1149 1147
123
I and to promote nerve regeneration (Livesey et al. 1997).
An interesting question is whether IL-6-mediated effects
on oligodendrocyte viability are either caused by direct
IL-6 actions on the oligodendrocyte or indirectly via neu-
ronal PAP I expression.
Among others, neurodegenerative mechanisms follow-
ing TBI may include cellular damage due to oxidative
stress and apoptosis. The results obtained herein on the
protection from H2O2-induced oxidative stress as well as
K?-deprivation induced apoptosis strongly suggest that
PAP I-induced neuroprotection is a common phenomenon
to neuronal subpopulations of different brain regions. In
order to define the potential protective role of PAP I on
central neurons, we have delineated the signaling mechanisms
contributing to PAP I-mediated neuron-specific effects. PAP I
leads to phosphorylation of Akt, p44/p42-MAP kinases as
well as of NFjB indicating that similar mechanisms are
used in brain as compared to the PNS. In contrast to the
neuroprotective effect of PAP I on spinal motor neurons
where inactivation of the PI3 kinase completely abolishes
PAP I-mediated neuron survival, brain neurons appear to
be only partially dependent on Akt/PI3 kinase signaling.
These results indicate that in central neurons, multiple
signaling pathways may converge and other signaling
cascades seem to participate additionally in PAP I-medi-
ated neuron survival. A marked upregulation of the IL-6
system following injury and neurodegeneration was
observed on various brain regions (Gadient and Otten
1997). IL-6 protects hippocampal and cerebellar neurons
against neurotoxicity (Sun et al. 2002; Peng et al. 2005),
ischemic damage (Yamashita et al. 2005) as well as lesion-
induced brain injury (Penkowa et al. 2003a, b; Cao et al.
2006). An interesting question is whether PAP contributes
to all these neuroprotective effects.
Remarkably, PAP I and PSP have been reported to be
increased in early stages of AD (Duplan et al. 2001).
Recently, we have shown that members of the PAP/Reg
protein family display highly aggregative properties under
physiological conditions after trypsin cleavage at the Arg-
Ile bond in position 11-12 (Graf et al. 2001). The generated
C-terminal fragment is largely insoluble at physiological
pH and readily polymerizes into organized fibrils; theses
structures are highly reminiscent of fibrillar deposits found
in brain tissues associated with diverse neurodegenerative
diseases. Generation of cleaved, misfolded peptides which
aggregate and accumulate often leads to neuronal dys-
function (Selkoe 2003; Soto 2003). However, it remains
unclear whether brain-specific cleavage of PAP-related
proteins occurs in intact brain and moreover whether these
cleaved proteins are involved in neuroprotective or neu-
rodegenerative processes.
In the study reported herein, we provide substantial
evidence for a key role of PAP I to protect brain neurons
against damaging stimuli. Additional studies are needed to
prove whether PAP I is directly responsible for the neu-
roprotective effects of IL-6 type cytokines in the brain or
whether additional regulatory stimuli are needed to induce
PAP I synthesis. Better understanding of the mechanisms
involved in PAP I receptor-mediated intrinsic survival
programs in brain neurons should help to develop novel
therapeutic strategies for neuroprotection.
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